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Abstract
Background. Neuro-oncology has grown tremendously since 2010, marked by increasing society membership, 
specialized clinical expertise, and new journals. Yet, modest improvement in racial/ethnic diversity amongst clinical 
trial participants, researchers, and clinicians led us to conduct a survey to identify opportunities to enhance diver-
sity and inclusiveness amongst neuro-oncology professionals.
Methods. In summer 2020, the Women and Diversity Committee of the Society for Neuro-Oncology (SNO) dis-
tributed an anonymous online survey to members and affiliates including the European Association of Neuro-
Oncology (EANO), Asian Society for Neuro-Oncology (ASNO), Society for Neuro-Oncology Latin America (SNOLA) 
and Society for Neuro-Oncology Sub-Saharan Africa (SNOSSA). The survey captured personal and professional 
characteristics, biases, effective mentorship qualities, career service metrics, and suggested field/society changes. 
Results were analyzed by geography, profession, age, racial/ethnic, and sexual identity. Standard descriptive sta-
tistics characterized the study population.
Results. The 386 respondents were predominantly female (58%) with a median age range of 40–49 years (31%), 
White (65%), and SNO members (97%). Most worked in North America (77%) in a research profession (67%). 
A majority of White respondents reported never experiencing biases (64%), while the majority of non-White re-
spondents reported unconscious biases/microaggressions, followed by a lack of/limited mentorship. Qualitative 
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assessments showcased that personal/professional success metrics were linked to needed improvements 
in diversity and inclusion efforts within the neuro-oncology field.
Conclusions. The prevalence of racial/ethnic biases and poor mentorship rates amongst underrepresented 
groups in neuro-oncology is high and potentially linked to the limited diverse representation amongst mem-
bers and affiliates. These findings warrant a swift implementation of equity and inclusion practices within 
the neuro-oncology field.
Introduction
In the current global awakening related to systemic racial 
injustice and historical exclusion, various institutions have 
been forced to reckon with their commitment to equity, 
diversity, and inclusion. As it relates to medicine, work-
force diversity in the United States (US) directly impacts 
health equity and disparities.1,2 According to the census 
estimates published in 2019, the racial/ethnic breakdown 
of the US population is comprised predominantly of 
non- Hispanic/White (60.1%), followed by Hispanic/Latino 
(18.5%), Black (13.4%), Asian (5.9%), American Indian/
Alaska Native (1.3%) and Native Hawaiian/Pacific Islander 
(0.2%).3 However, these numbers are not mirrored in the 
physician workforce during the same period with 56.2% 
of active physicians identifying as White, 17.1% Asian, 
5.8% Hispanic/Latino, 5% Black/African American, 0.3% 
Native, and 13.7% unknown. Prior to 2004, the racial/ethnic 
groups underrepresented in medicine (URiM) and re-
search have been historically defined as Blacks, Hispanic/
Latino, Native Americans/American Indians, and Hawaiian/
Pacific Islanders. More recently, this designation has been 
broadened to include any population underrepresented 
in medicine as compared to their numbers in the general 
population.4 Diverse representation among specialists, 
specifically in oncology, remains dismal with 5.8% of prac-
ticing oncologists identifying as Hispanic and 2.3% as 
Black/African American.
This lack of diversity in practicing clinicians has down-
stream effects on clinical care, namely for patients from 
racially and socioeconomically underserved communities. 
Indeed, when there is race and/or gender concordance be-
tween patients and physicians, improved communication, 
understanding, and quality of care can be translated to im-
proved patient survival and decreased morbidity rates. For 
example, Black patients who are cared for by Black phys-
icians were more likely to receive preventative services, 
adhere to their medications, and understand their treat-
ment plans.5–9 As we seek to deliver the highest quality of 
care to all, equitable representation of women and diverse 
populations in medicine will lead to a more comprehensive 
understanding of the spectrum and impact of the disease.
In 2018 the Women in Neuro-Oncology (WiN.) 
committee within the Society of Neuro-Oncology (SNO) 
was created with the mission of identifying the needs 
and advancing the careers of women in neuro-oncology. 
In 2019, WiN. issued a survey to SNO members seeking 
to understand biases experienced within the workplace, 
ultimately demonstrating that women experienced sig-
nificant bias in their respective workplaces regularly, 
with missed academic opportunities, salary discrep-
ancies, burnout, and a lack of mentorship being pre-
dominant themes.10 In early 2020, SNO expanded the 
society’s diversity efforts through the creation of the 
Women and Diversity Committee (WDC), which evolved 
from the combined efforts of WiN.  and the SNO diver-
sity task force of the clinical trials enrollment working 
Importance of the Study
While the field of neuro-oncology has grown over 
the last decade, it has failed to see a rise in racial/
ethnic diversity amongst clinical trial participants, 
researchers, and clinicians. This survey reports on 
the prevalence of perceived and realized biases that 
impact underrepresented groups, specifically their 
access to mentorship and career growth opportun-
ities within the field. There remains a need to increase 
equity and inclusion initiatives for patients, clinicians, 
and researchers throughout neuro-oncology.
Key Points
• The neuro-oncology field lacks racial/ethnic diversity in trial participants, 
researchers, and clinicians.
• This SNO survey details biases and career success metrics amongst members/
affiliates.
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group. Acknowledging the critical unmet needs within 
the neuro-oncology community, WDC was formed to ad-
dress membership engagement, and to improve research 
opportunities and clinical care for women and URiM. 
Collectively, the WDC holds a critical role in enhancing 
the success of women, underrepresented clinicians, 
and investigators early in their careers within neuro-
oncology. The initial charge for the WDC, as set forth by 
the SNO president and executive leadership, was to un-
derstand who SNO members and affiliates are, as well 
as to evaluate the unique needs, sense of career satis-
faction, concern for bias, and burnout of the underrep-
resented populations within our field. The findings from 
this questionnaire would aspire to then improve upon 
existing tools and prioritize new offerings to support 
SNO members and the neuro-oncology community at 
large. To date, these results are the first to clearly define 
the racial/ethnic demographic within neuro-oncology as 
well as the prevalence of experienced biases amongst 
SNO members and its affiliates.
Methods
The WDC developed a 27-question survey which was dis-
tributed via an anonymous survey link on three separate 
occasions in 2020: July 1, July 20, and July 28. Survey re-
cipients included all members of SNO and its international 
cooperative societies including the European Association 
of Neuro-Oncology (EANO), the Asian Society of Neuro-
Oncology (ASNO), the Society for Neuro-Oncology in Latin 
America (SNOLA), and the Society for Neuro-Oncology 
Sub-Saharan Africa (SNOSSA). Additionally, participants of 
recently registered SNO or SNO affiliate conferences were 
invited to complete the survey for further distribution of in-
dividuals within the neuro-oncology field. These 5 societies 
are composed of members including physicians, clinical 
and basic researchers, advanced practice providers and 
allied health professionals. At the time of the survey, the 
largest society, SNO, had 2077 members, 63% identifying 
as male, and 35% identifying as female. The survey was 
composed of three parts: (1) Eighteen demographic-
focused questions, (2) Seven questions focused on ex-
periences associated with bias, mentorship, and burnout, 
and (3) Two open-ended questions to allow for detailed 
suggestions for changes needed within the field of neuro-
oncology or SNO. The questions were developed by mem-
bers of the WDC based on prior SNO-developed surveys 
(Supplementary Figure 1). Demographic questions in-
cluded age, sex, race/ethnicity, disability, military service, 
and gender identification questions. Questions focused on 
current professional practice included degrees held, pro-
fessional activity, country of professional activity, type of 
practice (academic, hospital, private, university-based), 
years in practice, age of the treated patient population (pe-
diatric, adult, combination), membership and length of 
membership in their respective neuro-oncology societies. 
The second part of the survey explored aspects of career 
satisfaction and development. The rate of experienced 
bias was assessed utilizing a 7-point Likert scale ranging 
from “never experienced” to “experienced almost daily.” If 
respondents answered with any experience of racial/ethnic 
biases, the type of bias and period experienced were ex-
plored in subsequent questions. The next group of ques-
tions asked respondents to rank the categories felt to be 
most important for career success, allowing five answers 
in the level of importance. Participants were asked to rank 
up to the three most important attributes of mentorship. 
Respondents were then asked if they had an effective 
mentor (yes or no) or if they wanted or needed a mentor. 
Symptoms of burnout were assessed utilizing the 7-point 
Likert scale, also ranging from “never experienced” to “ex-
perienced almost daily”. In the last two questions of the 
questionnaire, participants were asked what would pro-
vide more personal and professional satisfaction and, spe-
cifically, what services, resources, and support they would 
like to see offered through SNO.
Statistical Analysis
A total of 8693 SNO and affiliate members received the 
survey with 386 completing the survey in full (4.4% re-
sponse rate). Rates for prior SNO-initiated surveys, 
including the SNO-EANO Burnout and WiN surveys 
were 7% and 10%, respectively. A  total of 494 partici-
pants began the SNO Diversity Metrics survey and an-
swered through question 3. By question 16, 108 (22%) 
participants stopped and answered through question 
3. By question 16, 108 (22%) participants stopped com-
pleting the survey, with an overall completion rate of 
78% among those who started the survey. There were 
no major differences in racial/ethnic identity frequen-
cies when using only the sample who answered the 
questionnaire in its entirety compared with the total 
participant sample. Each identity lost participants, ex-
cept for American Indian or Alaskan Native. All further 
analyses included data from 386 respondents who com-
pleted questions 1–27. All included surveys were evalu-
ated for completeness. Missing or incomplete surveys 
were excluded from the full detailed analysis. Survey 
respondents were analyzed as a total group and then 
sub-analyzed by location practice. Other analyzed 
items included sexual identity, racial/ethnic identifica-
tion, military participation, disability status of mem-
bers, degrees held, duration of time within the primary 
profession or at current institution, duration of SNO 
membership, and biologic age range. Evaluation of re-
spondent answers to questions regarding bias, men-
torship, and burnout addressed differences related to 
geographical location, racial/ethnic identity, URiM vs. 
non-URiM status, age, and sexual identity. Standard 
descriptive statistics were utilized to characterize the 
study population. Mean, standard deviation, range and 
quartiles were calculated for years in SNO, years in 
practice, and years in current position. Median age was 
calculated of participants due to categorical range se-
lection options. For analysis of mentorship associations 
with the reported demographic variables, chi-square 
tests and one-way ANOVA testing was utilized with sig-
nificance defined as P < .05. A  thematic approach was 
used to code the free-text responses, each response 
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software (MAXQDA) to identify recurring themes. One 
author who has had training in the methods and prin-
ciples of qualitative research work reviewed text re-
sponses and any questions regarding the codes and 
themes of the analysis were reviewed with additional 
authors. The process followed in creating the themes 
included re-reading the text to understand participant 
responses, developing categories (parent codes) based 
on the topics identified, then coding open-ended text 
responses and adding coded text to categories while 
creating subcategories if needed. The coding process 
was initiated by highlighting sections of the text that 
described the answers to the question and each was la-
beled with a code to describe the content. Similar codes 
were grouped together, which led to generating themes 
(parent codes) that the codes could be placed under. 
After this process, direct sub-codes (subcategories of 
parent codes) and lower-level codes (codes under direct 
sub-codes) were created to provide more detailed ex-
planations of the parent codes identified to understand 
participants' overall experience. The analysis includes a 
count of the number of participants in which each of the 
parent codes and sub-codes occurs.
To generate the word clouds, word frequencies were 
identified in the MAXQDA software. For each question, 
the most frequent words used by participants shaped the 
word cloud and a stop list was created to remove any small 
words or basic language (“and,” “the,” etc.) that weren’t 
meaningful to the analysis.
Results
Demographics and Participant Characteristics
Responses from 386 individuals represented 26 coun-
tries, with most participants from North America (82%) 
(Table 1). The median age range was 40–49  years old 
(31%) with a female predominance (58%). Sixty-five per-
cent of respondents identified as White, 13% Asian, 12% 
Hispanic or Latino, 9% Asian Indian, 5% Black/African 
American, 1% American Indian or Alaskan Native, 1% 
Native Hawaiian or Islander, and 3% Other. Seven per-
cent of participants identified with multiple racial/ethnic 
groups, with a predominance of these being White-
Hispanic (2%) respondents. Eight percent of participants 
identified as lesbian, gay, bisexual, transgender, queer, 
intersex, or asexual. Additionally, a minority of respond-
ents reported disabilities (3%) and active military, re-
serve, or natural guard status (1%).
Membership Characteristics
A total of 373 (97%) of participants held SNO memberships, 
while 11% held EANO membership; and 12% of respond-
ents held dual membership amongst varied societies. For 
those who were SNO members, the mean duration was 
7.6  years, with a range between 1–25  years. Participants 
who practiced in North America reported being SNO mem-
bers for 2.3 years longer than participants who practiced in 
other countries.
Clinical/Research/Professional Focus
Eighty-two percent of respondents primarily practiced 
or conducted research and/or administrative work within 
North America. Participants primarily held clinical doc-
torates (66%), followed by non-clinical doctorates (34%) 
and/or master’s degrees (22%). The primary Professional 
focus leaned towards research (67%), followed by med-
ical (53%) and education (20%); however, 46% of re-
spondents reported multiple professional foci. Among 
the researchers, 70% were conducting translational re-
search and for respondents providing clinical care, 70% 
were caring for adult patients (Table 2). Clinicians pre-
dominately reported practicing in an academic (62%) 
setting. On average, participants reported being in their 
primary professional focus for 14.3  years and in their 
current positions for 7.7 years.
Reported Biases
Participants were asked a series of questions centered 
around frequency, incidence, and type of racial/ethnic 
biases experienced to date (Figure 1, Supplementary Table 
1). White respondents were the largest proportion of par-
ticipants who reported never experiencing biases (64%). 
Among the respondents reporting biases, Black/African 
Americans reported the highest frequency at once a month 
(22%) or every day (17%), while Hispanics reported 26% 
experiencing biases once a month, 9% once a week, and 
9% every day. A chi-square test revealed a significant as-
sociation between being URiM member and experiencing 
ethnic/racial bias in work (X2(1) = 17.9, P < .001, OR = 3.4). 
Overall, URiM respondents were 3.4 times more likely to 
experience ethnic/racial bias in work than non-URiM re-
spondents. The highest frequency within other racial/
ethnic groups was in the once a month category with 40% 
American Indians or Native Americans, 24% Asians, 21% 
Asian Indians, and 50% Native Hawaiian/Pacific Islanders 
(Figure 1). Collectively for all participants, the predomi-
nant bias type was “not being invited to participate and/or 
being considered for professional opportunities as others 
in comparable rank”. In detailing the type of biases expe-
rienced by ethnic/racial identification, an overwhelming 
majority of non-White respondents reported unconscious 
biases/microaggressions, followed by a limited/lack of 
mentorship. With respect to timing, on average, 41% of all 
respondents reported a remote history (>1 month prior), 
while 35% reported a trend of biases at their current institu-
tion. Interestingly, there was no significant difference in the 
timing of biases when evaluating by ethnic/racial groups.
Career Success Metrics
In the evaluation of the metrics associated with career 
progress/success, all respondents were asked to rank the 
importance of various categories: work collegiality, eq-
uitable salary, funding and/or resource allocation, equi-
table work distribution, mentorship/mentee opportunities, 
promotion opportunities, opportunity to hold leadership 
role(s) and authorship (Figure 2). While evaluating total 
  
Table 1 Demographics
Primary country of work Total  
N = 386




N (%) N (%) N (%)
North America 317 (82%)  
 United States 298 (77%)  
 Canada 18 (5%)  
 Mexico 1 (<1%)  
South America 6 (2%)  
 Argentina 2 (1%)  
 Brazil 4 (1%)  
Europe 43 (11%)  
 Austria 3 (1%)  
 Demark 1 (<1%)  
 Germany 8 (2%)  
 Hungary 1 (<1%)  
 Israel 1 (<1%)  
 Italy 4 (1%)  
 Lebanon 1 (<1%)  
 Netherlands 7 (2%)  
 Poland 1 (<1%)  
 Spain 2 (1%)  
 Sweden 1 (<1%)  
 Switzerland 2 (1%)  
 United Kingdom 11 (3%)  
Asia 12 (3%)  
 India 5 (1%)  
 Indonesia 1 (<1%)  
 Japan 1 (<1%)  
 Pakistan 1 (<1%)  
 Republic of Korea 3 (1%)  
 Thailand 1 (<1%)  
Africa 0  
Oceania 8 (2%)  
 Australia 7 (2%)  
 New Zealand 1 (<1%)  
Professional society    
SNO 373 (97%) 316 (100%) 57 (81%)
EANO, ASNO, SNOLA, SNOSSA 59 (16%) 13 (5%) 46 (66%)
Multiple 45 (12%) 13 (4%) 32 (46%)
Sex    
Female 223 (58%) 178 (56%) 45 (64%)
Male 160 (41%) 135 (43%) 25 (36%)
Prefer not to say 3 (1%) 3 (1%) 0 (0)
Age    
21–29 31 (8%) 29 (9%) 2 (3%)
30–39 108 (28%) 88 (28%) 20 (29%)
40–49 118 (31%) 96 (30%) 22 (31%)
50–59 69 (18%) 49 (16%) 20 (29%)
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Table 1 Continued
responses, White and Asian respondents overwhelmingly 
ranked the opportunity to hold leadership role(s) as the 
highest importance. In contrast, Black/African American re-
spondents reported work collegiality as paramount (56%), 
and Hispanics ranked having an equitable salary as the 
highest importance (47%). Participants were then asked 
to select the three most effective mentorship attributes 
for success. Interestingly, in the breakdown of race/eth-
nicity, most of the groups also ranked critical feedback and 
serving as a good advocate to be crucial for effective men-
torship. Among North American respondents, critical feed-
back and the ability to be a good advocate were identified 
as key qualities in a mentor, while respondents from other 
countries reported that the identification of opportunities 
was an essential quality for a great mentor. Additional 
free-text responses not included in selected categories in-
cluded: sponsorship for opportunities and transparency in 
career goals.
Lastly, we asked which of the respondents had effective 
mentorship currently. Fifty-three percent of total partici-
pants had effective mentorship, with higher percentages 
within North America (55%) as compared to other coun-
tries (43%). A  chi-square test revealed a significant as-
sociation between effective mentorship and age group 
(X2(12) = 86.1, P < .001, Cramer’s V = 0.27). More partici-
pants in the younger age groups (21–29, 30–29) reported 
having an effective mentor than participants in other age 
groups (Supplementary Table 1). While more participants 
in the 50–59 age group reported not having a mentor than 
in other age groups, more participants in the 60 and older 
age group reported not needing/wanting a mentor than 
the other age groups. One-way ANOVA also revealed a 
significant difference in the years of SNO membership 
in relation to effective mentorship (F(3,369)  =  23.0, P < 
.001). Participants who reported not needing or wanting 
a mentor were SNO members longer than participants in 
Primary country of work Total  
N = 386




N (%) N (%) N (%)
Identification    
White 250 (65%) 198 (63%) 52 (74%)
Black or African American 18 (5%) 18 (6%) 0 (0)
Hispanic or Latino 47 (12%) 42 (13%) 5 (7%)
American Indian or Alaskan Native 49 (13%) 5 (1%) 0 (0)
Asian 63 (13%) 39 (12%) 10 (14%)
Asian Indian 34 (9%) 29 (9%) 5 (7%)
Native Hawaiian or Pacific Islander 4 (1%) 3 (1%) 1 (1%)
Other 10 (3%) 8 (3%) 2 (3%)
Multiple 26 (7%) 23 (7%) 3 (4%)
LGBTQIA    
Yes 30 (8%) 27 (9%) 3 (4%)
No 354 (92%) 287 (91%) 67 (96%)
Disabilities    
Yes 11 (3%) 8 (3%) 3 (4%)
No 374 (97%) 307 (97%) 67 (96%)
Military    
Yes 2 (1%) 2 (1%) 0 (0)
No 383 (99%) 313 (99%) 70 (100%)
Highest degree    
Doctorate 335 (87%) 270 (85%) 65 (93%)
 Clinical 255 (66%) 208 (66%) 47 (67%)
 Non-Clinical 132 (34%) 107 (34%) 25 (36%)
Masters/Advanced 24 (6%) 20 (6%) 4 (6%)
Nursing 7 (2%) 6 (2%) 1 (1%)
Bachelors 19 (5%) 19 (6%) 0 (0)
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Table 2 Professional Characteristics




Other countries   
N = 70 (18%)
N (%) N (%) N (%)
Research 257 (67%) 212 (67%) 45 (64%)
Basic: 101 (39%) Basic: 85 (40%) Basic: 16 (36%)
Clinical: 148 (58%) Clinical: 116 (55%) Clinical: 32 (71%)
Translational: 181 (70%) Translational: 151 (71%) Translational: 30 (67%)
Medical 205 (53%) 170 (54%) 35 (50%)
Education 78 (20%) 60 (19%) 18 (26%)
Surgical 62 (16%) 47 (15%) 15 (21%)
Administration 46 (12%) 37 (12%) 9 (13%)
Industry 12 (3%) 12 (4%) 0 (0%)
Other 7 (2%) 5 (2%) 2 (3%)
Treatment population    
Adult 269 (70%) 217 (69%) 52 (74%)
Pediatrics 60 (16%) 52 (16%) 8 (11%)
Both 57 (15%) 47 (15%) 10 (14%)
Specialty focus    
Neuro-oncology 295 (76%) 237 (75%) 58 (83%)
Laboratory research 79 (20%) 63 (20%) 16 (23%)
Neurosurgery 72 (19%) 54 (17%) 18 (26%)
Neurology 51 (13%) 38 (12%) 13 (39%)
Medical oncology 45 (12%) 32 (10%) 13 (19%)
Pediatrics 41 (11%) 35 (11%) 6 (9%)
Radiation oncology 39 (10%) 30 (9%) 9 (13%)
Pathology 24 (6%) 19 (6%) 5 (7%)
Epidemiology 20 (5%) 14 (4%) 6 (9%)
Radiology 17 (4%) 11 (3%) 6 (9%)
Statistics 16 (4%) 14 (4%) 2 (3%)
Psychology 11 (3%) 5 (2%) 6 (9%)
Pharmacology 10 (3%) 5 (2%) 5 (7%)
Industry 9 (2%) 9 (3%) 0 (0%)
Nursing 8 (2%) 5 (2%) 3 (4%)
Allied Health 7 (2%) 6 (2%) 1 (1%)
Foundation 4 (1%) 3 (1%) 1 (1%)
Other 10 (3%) 8 (3%) 2 (3%)
Primary setting for clinical positions    
Academic 241 (62%) 202 (64%) 39 (56%)
Hospital based 113 (29%) 79 (25%) 34 (49%)
Private practice 25 (6%) 18 (6%) 7 (10%)
Nonprofit 23 (6%) 18 (6%) 5 (7%)
Government 14 (4%) 7 (2%) 7 (10%)
Industry 10 (3%) 10 (3%) 0 (0%)
Non-clinical position 16 (4%) 12 (4%) 4 (6%)
Other 3 (1%) 3 (1%) 0 (0%)
Number of years in primary focus    
Mean (SD) 14.3 (11.0) 13.9 (11.3) 15.7 (9.7)
Number of years in current position    
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the three other categories (16.4 years vs 6.1–8.8 years) (P 
< .001). More participants having longer SNO member-
ships reported not having effective mentors as compared 
to shorter-term SNO members (8.8 years and 6.1 years, re-
spectively) (P < .01). In the evaluation of other categories, 
respondents less than one year of primary professional 
focus, Asian identity, and the professional “research” 
focus groups were the largest group to report having effec-
tive mentorship at the time of the 288 surveys (81%, 68%, 























































































































































































































baptisthealth.net user on 07 Septem
ber 2021









Professional burnout can be described as a constellation 
of symptoms, including but not limited to the following: 
state of emotional exhaustion, depersonalization, and loss 
of personal achievement. We surveyed participants about 
the frequency of symptoms of burnout experienced; with 
further exploration of any differences related to gender, ra-
cial/ethnicity, and professional focus (Supplementary Table 
2).11 The overall majority of our total respondents reported 
symptoms of burnout once every few months (27%). There 
were no observed differences among ethnic/racial groups 
in burnout symptom rate. A  chi-square test revealed no 
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symptoms and sexual identity. Like the WiN survey, 90% 
of respondents reported having some frequency of symp-
toms of burnout (Figure 3).
Neuro-Oncology Professional Outlook
Parent codes generated around personal and professional 
satisfaction included such categories as personal and 
professional improvements, more open community, and 
healthy work environments. Common themes within per-
sonal and professional satisfaction included mentorship, 
opportunity, and advancement (Figure 3, Supplementary 
Table 3). Common parent codes found amongst recom-
mendations for change within SNO included categories 
such as personal and professional improvements, more 
opportunities for inclusion, support, and opportunities 
for involvement and engagement. Common themes 
within recommendations of SNO changes included net-
working, mentorship, and opportunity. We selected spe-
cific comments that helped to further illustrate common 
themes around personal and professional satisfaction. 
Overall qualitative evaluation of these answers points to-
wards a better sense of community and inclusion needed 
to foster achievements and success within SNO and the 
neuro-oncology field.
“Feeling like I have place to sit at the table. I love collab-
oration but exclusion re: career opportunities, social activ-
ities etc. is hurtful and I resent spending my time focused 
on these things vs. moving our field forward.”
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“Genuine collaboration towards a common goal that al-
lows everyone to participate and be recognized, valued for 
what they can offer.”
“A more inclusive and diverse environment. We need 
to increase the number of people from underrepresented 
backgrounds (women, LGBTQIA, lower socioeconomic 
status, racial/ethnic minorities).”
“Not experiencing the gender discrimination rampant 
at my institution which actively limited resources for my 
research.”
“Increased female leadership roles and mentorship op-
portunities. Especially for female early career researchers 
trying to start a family.”
“More mentorship opportunities for trainees would be 
wonderful. Specifically, accessibility to physician-scientist 
mentors in the field of neurosurgery/neuro-oncology.”
Discussion
The SNO diversity survey is the first evaluation of the dem-
ographics, membership characteristics, and experiences 
of bias reported by the members of SNO and its interna-
tional affiliates. This work follows the efforts of other med-
ical organizations such as the American Society of Clinical 
Oncology (ASCO) and the American Association of Medical 
Colleges (AAMC); which assessed the demographics of 
their membership to create a workforce that reflects the 
larger, general US population. Of the 386 respondents who 
completed the SNO survey, 65% self-identified as non-
Hispanic White, consistent with representation in medicine 
and the general US population. This survey aimed to cap-
ture a representation of groups historically referred to as 
URiM, defined by the AAMC as “racial/ethnic populations 
that are underrepresented in the medical profession rela-
tive to their numbers in the general population”. Asians, in-
clusive of respondents who identified as East and/or South 
Asian, represented 22% of the survey participants. Racial/
ethnic groups which have been historically associated as 
populations within URiM include Latino/Hispanic, Black/
African American, and American Indian/Alaskan Native, 
and represented 12%, 5%, and 1% of survey respondents, 
respectively.
In consideration of experiences of bias, all racial/ethnic 
categories reported experiencing some biases. Among 
White respondents, 64% reported never experiencing bias. 
Conversely, Black/African Americans and Latino/Hispanic 
respondents reported experiencing some form of bias 
daily, commonly noting microaggressions as well as a 
lack of effective mentorship. The impact of bias on URiM 
physician trainees was studied by Osseo-Asare et al.12 In 
a survey of minority resident physicians, additional chal-
lenges beyond those experienced by non-minority coun-
terparts were identified, including microaggressions, lack 
of formal reporting mechanisms for experiences of bias, 
and a lack of belonging. These findings demonstrate the 
compounding impact of experienced biases amongst 
clinicians, in an already high-pressure and stressful time 
period of training.12 The downstream complications of this 
may be lower job satisfaction and higher turnover rates, 
which in turn has an impact on overall patient care.13 In a 
recently published SNO survey, which evaluated burnout 
and career satisfaction amongst practitioners caring for 
brain tumor patients, 63% of SNO and 61% of EANO partici-
pants were identified as having high scores consistent with 
symptoms of burnout according to the MBI-HSS (Maslach 
Burnout Inventory-Human Services Survey) question-
naire.11 In comparison, the WiN. SNO survey (where the 
majority of respondents were female), found that 94% of 
respondents reported having some frequency of burnout10. 
In this diversity survey, while there were no differences in 
the frequency of burnout related to race/ethnicity, the ex-
perience, and frequency of bias are likely to contribute to 
a lack of engagement linked with low career and personal 
fulfillment.
Like the general physician workforce, notably in 
Oncology, there continues to be a trend of inadequate 
representation of racial and ethnic minorities in medical 
specialties. The recent ASCO Workforce Diversity survey 
demonstrated that 2% of practicing oncologists in the US 
identified as Black/African American, as compared to the 
general US population of 13%.
Furthermore, Hispanic oncologists represented 3% of US 
oncologists, though 18% of the US population is Hispanic 
(ASCO Workforce Diversity statement).4 These studies 
have shown that diversity and representation within the 
oncology workforce expand and improves healthcare ac-
cess, clinical trial recruitment, and research databases 
to help in reducing health care disparities.4,13,14 In com-
parison, while the ASCO membership is larger than SNO 
and SNO affiliates, this survey also demonstrates the low 
representation of racial/ethnic diversity within the clinical 
and research membership, linking these low numbers to 
significant influences to both personal and professional 
successes amongst SNO and affiliate members and specif-
ically within URiM groups.
Limitations
Though instructive, this optional survey might be prone 
to biases inherent to all survey studies; since data gen-
erated is based on the experiences of those who chose 
to respond and might not be generalizable to the en-
tire membership. Our response rate is hard to estimate 
given the various groups (members and nonmembers) 
we reached out to and their changing membership, but 
it likely was a small percentage of the total. Additionally, 
members of the neuro-oncology community are hetero-
geneous in their professional backgrounds and their ex-
periences vary widely based on professional circumstance 
and geographic location. Taken as a whole, the results of 
this study are meant to raise awareness of the issues of 
women and URiM SNO members, with reach to associated 
stakeholders.
Conclusion
The results of this survey demonstrate that consistent with 
trends in oncology and other medical specialties, despite 
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representation, there remains a lack of diversity in the ra-
cial/ethnic make-up of clinicians and researchers. Biases 
and discrimination are consistent themes reported by di-
verse members, the impact of which contributes to a lack 
of engagement, career development, and/or success. 
Concentrated programming directed towards SNO and its 
affiliate society members can begin to mitigate these chal-
lenges by developing and expanding opportunities spe-
cifically for leadership and promotion of URiM members, 
thus leading to a more equitable workforce. Specifically, 
the ASCO Strategic Plan for Increasing Racial and Ethnic 
Diversity in the Oncology Workforce is utilizing a three-
pronged approach to this charge by addressing inclusion 
at the (1) trainee, (2) leadership, and (3) policy level.4 Their 
strategic plan was built from learning the large impact di-
versity within the oncology field has on decreasing mor-
bidity and mortality rates in underserved and vulnerable 
populations. Collectively, establishing an inclusive pro-
gram to improve belongingness within organizations 
where its members and community feel heard and un-
derstood with respect to their personal and professional 
needs is essential. While initial steps have been taken 
to expand the SNO Women in Neuro-oncology to SNO 
Women and Diversity Committee, these efforts are just the 
start of long-needed efforts to have the neuro-oncology 
field reflect the patient population. Additional work is re-
quired to routinely assess how the current societal climate 
and workforce cultures can further shape needed changes 
within the field. Specifically, as the mission of SNO is to 
“promote advances in neuro-oncology through research 
and education,” it is evident from these survey findings 
that a representative membership is essential to ensuring 
this mission is achieved, with the intent that its members, 
affiliates, and patients mutually thrive.
Supplementary Material
Supplementary material is available at Neuro-Oncology 
online.
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